ASPEN AEROGELS INC (ASPN) Stock Fundamental Analysis
NYSE:ASPN - New York Stock Exchange, Inc. - US04523Y1055 - Common Stock - Currency: USD
Taking everything into account, ASPN scores 4 out of 10 in our fundamental rating. ASPN was compared to 85 industry peers in the Chemicals industry. Both the profitability and the financial health of ASPN get a neutral evaluation. Nothing too spectacular is happening here. ASPN shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
In the past year ASPN was profitable.
In the past year ASPN had a positive cash flow from operations.
In the past 5 years ASPN reported 4 times negative net income.
ASPN had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
The Return On Assets of ASPN (1.49%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 2.18%, ASPN is in line with its industry, outperforming 47.06% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 6.55%, ASPN is in the better half of the industry, outperforming 64.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.49% | ||
| ROE | 2.18% | ||
| ROIC | 6.55% |
ROA(3y)-5.96%
ROA(5y)-12.11%
ROE(3y)-8.57%
ROE(5y)-17.34%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ASPN has a Profit Margin of 2.95%. This is comparable to the rest of the industry: ASPN outperforms 57.65% of its industry peers.
ASPN's Operating Margin of 12.82% is fine compared to the rest of the industry. ASPN outperforms 71.76% of its industry peers.
Looking at the Gross Margin, with a value of 40.40%, ASPN belongs to the top of the industry, outperforming 83.53% of the companies in the same industry.
In the last couple of years the Gross Margin of ASPN has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.82% | ||
| PM (TTM) | 2.95% | ||
| GM | 40.4% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y70.57%
GM growth 5Y16.45%
2. Health
2.1 Basic Checks
ASPN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ASPN has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ASPN has been increased compared to 5 years ago.
ASPN has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.05, we must say that ASPN is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.05, ASPN is doing worse than 72.94% of the companies in the same industry.
ASPN has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ASPN (0.24) is better than 75.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.24 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.05 |
ROIC/WACC0.76
WACC8.63%
2.3 Liquidity
A Current Ratio of 3.72 indicates that ASPN has no problem at all paying its short term obligations.
ASPN's Current ratio of 3.72 is amongst the best of the industry. ASPN outperforms 89.41% of its industry peers.
A Quick Ratio of 3.29 indicates that ASPN has no problem at all paying its short term obligations.
The Quick ratio of ASPN (3.29) is better than 90.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.72 | ||
| Quick Ratio | 3.29 |
3. Growth
3.1 Past
ASPN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 178.79%, which is quite impressive.
Looking at the last year, ASPN shows a very strong growth in Revenue. The Revenue has grown by 89.63%.
ASPN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.56% yearly.
EPS 1Y (TTM)178.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1500%
Revenue 1Y (TTM)89.63%
Revenue growth 3Y54.99%
Revenue growth 5Y26.56%
Sales Q2Q%46.15%
3.2 Future
ASPN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.38% yearly.
Based on estimates for the next years, ASPN will show a very strong growth in Revenue. The Revenue will grow by 28.20% on average per year.
EPS Next Y-78.2%
EPS Next 2Y9.3%
EPS Next 3Y25.87%
EPS Next 5Y41.38%
Revenue Next Year-12.5%
Revenue Next 2Y8.87%
Revenue Next 3Y12.28%
Revenue Next 5Y28.2%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 10.61 indicates a reasonable valuation of ASPN.
ASPN's Price/Earnings ratio is a bit cheaper when compared to the industry. ASPN is cheaper than 80.00% of the companies in the same industry.
ASPN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.92.
With a Price/Forward Earnings ratio of 48.65, ASPN can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ASPN indicates a slightly more expensive valuation: ASPN is more expensive than 64.71% of the companies listed in the same industry.
ASPN's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.65.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.61 | ||
| Fwd PE | 48.65 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ASPN is valued cheaper than 91.76% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 4.94 |
4.3 Compensation for Growth
ASPN's earnings are expected to grow with 25.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.3%
EPS Next 3Y25.87%
5. Dividend
5.1 Amount
No dividends for ASPN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSE:ASPN (4/25/2025, 1:07:43 PM)
5.515
+0.05 (+1.01%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners93.09%
Inst Owner Change0.12%
Ins Owners1.46%
Ins Owner Change0.65%
Market Cap452.78M
Analysts81.33
Price Target17.85 (223.66%)
Short Float %12.99%
Short Ratio4.23
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)200.61%
Min EPS beat(2)57.28%
Max EPS beat(2)343.94%
EPS beat(4)4
Avg EPS beat(4)203.03%
Min EPS beat(4)57.28%
Max EPS beat(4)343.94%
EPS beat(8)8
Avg EPS beat(8)127%
EPS beat(12)9
Avg EPS beat(12)82.01%
EPS beat(16)10
Avg EPS beat(16)55.42%
Revenue beat(2)1
Avg Revenue beat(2)2.54%
Min Revenue beat(2)-0.11%
Max Revenue beat(2)5.19%
Revenue beat(4)3
Avg Revenue beat(4)10.62%
Min Revenue beat(4)-0.11%
Max Revenue beat(4)23.52%
Revenue beat(8)5
Avg Revenue beat(8)6.91%
Revenue beat(12)8
Avg Revenue beat(12)5.04%
Revenue beat(16)11
Avg Revenue beat(16)5.99%
PT rev (1m)-6.8%
PT rev (3m)-41.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-210.79%
EPS NY rev (1m)-50.81%
EPS NY rev (3m)-76.51%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-20.51%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-21.33%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.61 | ||
| Fwd PE | 48.65 | ||
| P/S | 1 | ||
| P/FCF | N/A | ||
| P/OCF | 9.94 | ||
| P/B | 0.74 | ||
| P/tB | 0.74 | ||
| EV/EBITDA | 4.94 |
EPS(TTM)0.52
EY9.43%
EPS(NY)0.11
Fwd EY2.06%
FCF(TTM)-0.5
FCFYN/A
OCF(TTM)0.55
OCFY10.06%
SpS5.51
BVpS7.49
TBVpS7.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.49% | ||
| ROE | 2.18% | ||
| ROCE | 7.39% | ||
| ROIC | 6.55% | ||
| ROICexc | 9.12% | ||
| ROICexgc | 9.12% | ||
| OM | 12.82% | ||
| PM (TTM) | 2.95% | ||
| GM | 40.4% | ||
| FCFM | N/A |
ROA(3y)-5.96%
ROA(5y)-12.11%
ROE(3y)-8.57%
ROE(5y)-17.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y70.57%
GM growth 5Y16.45%
F-Score7
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.24 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 1.83 | ||
| Cap/Depr | 382.94% | ||
| Cap/Sales | 19.06% | ||
| Interest Coverage | 8.28 | ||
| Cash Conversion | 56.53% | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.72 | ||
| Quick Ratio | 3.29 | ||
| Altman-Z | 1.05 |
F-Score7
WACC8.63%
ROIC/WACC0.76
Cap/Depr(3y)1152.87%
Cap/Depr(5y)727.63%
Cap/Sales(3y)63.74%
Cap/Sales(5y)41.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)178.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1500%
EPS Next Y-78.2%
EPS Next 2Y9.3%
EPS Next 3Y25.87%
EPS Next 5Y41.38%
Revenue 1Y (TTM)89.63%
Revenue growth 3Y54.99%
Revenue growth 5Y26.56%
Sales Q2Q%46.15%
Revenue Next Year-12.5%
Revenue Next 2Y8.87%
Revenue Next 3Y12.28%
Revenue Next 5Y28.2%
EBIT growth 1Y217.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year9.85%
EBIT Next 3Y39.81%
EBIT Next 5Y38.11%
FCF growth 1Y81.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y206.89%
OCF growth 3YN/A
OCF growth 5YN/A